Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Mediquix AB
AB
Active
Org 5594250572
Häggången 5
General medical practice activities · NACE 8621
Est. 2023
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 1,9M
+35% vs 2023
EBITDA margin
35.6%
+13% vs 2023
Equity ratio
48.6%
Financial strength
Net profit 2024
SEK 396K
+13% vs 2023
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 1,9M
+35%
EBITDA
SEK 662K
+13%
Net profit
SEK 396K
+13%
Total assets
SEK 1,6M
+74%
Equity
SEK 772K
+105%
Employees
—
—
Company information
Legal name
Mediquix AB
Org number
5594250572
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 mars 2023
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall tillhandahålla personaluthyrning, konsultverksamhet, rådgivning, försäljning och tillhörande tjänster inom medicin- och vårdsektorn.
Contact
Address
Häggången 5
Email
kaleta.s.victor@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
1 385
1 863
Staff expenses
−541
−922
EBITDA
587
662
Depreciation & amort.
—
—
EBIT
587
662
Net financials
0
−1
Profit before tax
442
501
Tax
−91
−105
Net profit
351
396
Balance sheet
SEK thousands
Item
2023
2024
Total assets
913
1 590
Equity
376
772
Long-term debt
20
0
Short-term debt
372
513
Total debt
392
513
Financial ratios
5-year trend
EBITDA margin
35.6%
This company
15.8%
Market median
+125% vs market
2023
2024
Equity ratio
48.6%
This company
38.2%
Market median
+27% vs market
2023
2024
Return on equity
51.3%
This company
18.4%
Market median
+179% vs market
2023
2024
Net profit margin
21.3%
This company
8.1%
Market median
+163% vs market
2023
2024
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
2023
2024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-03-07 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
VS
Victor Stefan Kaleta
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
OL
Olivia Linnéa Kaleta
Deputy Board Member
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Mediquix AB also hold positions in
0
other companies.
Person
Role here
Other companies
Victor Stefan Kaleta
Chief Executive Officer
0 companies
Olivia Linnéa Kaleta
Deputy Board Member
0 companies